QLS Advisors

QLS Advisors is a private life sciences technology and advisory firm focused on the healthcare sector. The company applies quantitative finance, machine learning, and fundamental biomedical analysis to evaluate portfolios of biomedical assets, estimate probabilities of success, model correlations across therapeutic areas, and inform capital allocation and risk management. Its clients appear to be investors and organizations seeking investment management and strategic decision support rather than drug development services. Founded in 2019 in Cambridge, Massachusetts, the firm sits at the intersection of healthcare, data science, and financial engineering. In 2025, QLS Technologies was launched as a spinout from QLS Advisors to commercialize an AI-powered portfolio modeling platform for drug development and innovation strategy.